Results
1
Companies which are potentially undervalued and in an acceptable financial position.
1 companies
Hypera
Market Cap: R$14.6b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$20.80
7D
-1.3%
1Y
-24.4%